Health Care
Corteria news and milestones
Corteria: 9 headlines on record, 1 headline in the last 90 days. Its story counts 2 milestones.
Data updated Nov 17, 2026 · Back to the company report
9Headlines
1In 90 days
2Milestones
Headlines
Sep 162026
Blog
We are excited to announce that preclinical data on COR-1389, the first-in-class and best-in-class CRF2 receptor agonist, will be presented at EASD 2026 in Milan! COR-1389 is des…
Jul 25, 20252025
News · usinenouvelle.com
Jul 21, 20252025
Blog
COR-1167 is entering Phase 2 clinical trial for the treatment of Worsening Heart Failure after obtaining promising Phase 1 data, while the Phase 1 of COR-1389 is ongoing for the…
Jul 21, 20252025
Jun 28, 20242024
Blog
At ESC HF 2024 in Lisbon, during an oral presentation, new data data of our CRF2 peptide agonist COR-1167 were released. On top of furosemide, COR-1167 reduced elevated cardiac f…
Mar 27, 20242024
Mar 26, 20242024
Blog
Corteria team is very proud to announce the initiation of COR-1167 first-in-human study. COR-1167 is a first-in-class corticotropin-releasing hormone receptor 2 (CRF2) agonist. A…
Jan 8, 20242024
Blog
Paris (France), 05 January 2024 - Corteria Pharmaceuticals ("Corteria"), a biopharmaceutical company specialized in the development of transformative therapies for heart failure…
Sep 6, 20232023
News · bioworld.com
As part of its quest to advance its three first-in-class heart failure drug candidates toward the clinic, Corteria Pharmaceuticals SAS has closed an oversubscribed €65 million (U…
Sources: the outlets named on each headline, each story once
Milestones
2019
Founded
Each milestone is dated by its source: registers, filings, the press
How to cite
Corteria, News. Alion, Nov 17, 2026. https://alion.io/company/corteriapharma/news
